Acurx Pharmaceuticals, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $61.00K, a 44.59% decline year-over-year.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $45.06K, a 62.88% decline year-over-year.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $86.18K, a 59.63% decline year-over-year.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $110.08K, a 63.98% decline year-over-year.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2025 was $322.32K, a 61.34% decline from fiscal 2024.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2024 was $833.68K, a 48.98% increase from fiscal 2023.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2023 was $559.58K, a 29.93% increase from fiscal 2022.
- Acurx Pharmaceuticals, Inc. stock issued during period, value, issued for services for fiscal 2022 was $430.68K, a 72.87% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $61.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $322.32K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $45.06K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $86.18K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $110.08K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $833.68K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $121.40K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $213.50K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $305.60K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $559.58K 10-K · filed 2025-03-17 | |
| 2023-03-31 | $165.90K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $430.68K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $127.08K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $188.10K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $1.59M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $1.33M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $37.50K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $135.47K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $572.11K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $131.65K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $161.10K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $181.10K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |